Clinical Trials · NCT00298155
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Washington
- Enrollment
- 35
- Start date
- Jul 2006
- Locations
- 2 sites, United States
- Primary endpoint
- Prostate Tissue DHT